SCHEMBL5878809

SCHEMBL5878809

CCC(CC)CCCCCCCCCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTK1 Q9Y2Q3 2/20 0.61
FFAR4 Q5NUL3 2/20 0.59
FFAR1 O14842 2/20 0.59
ALDH1A1 P00352 3/20 0.57
GPR84 Q9NQS5 7/20 0.56
PPARG P37231 7/20 0.56
PPARD Q03181 7/20 0.56
PPARA Q07869 7/20 0.56
HDAC11 Q96DB2 5/20 0.56
TSHR P16473 5/20 0.56
PTPN1 P18031 3/20 0.56
TLR2 O60603 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
FABP4 P15090 2/20 0.56
SLC22A6 Q4U2R8 1/20 0.56
SLC22A8 Q8TCC7 1/20 0.56
MEN1 O00255 1/20 0.56
ESR1 P03372 1/20 0.56
ALOX15 P16050 1/20 0.56
PDE4A P27815 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5879086 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL5878908 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL5878944 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL541769 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL3626080 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL3005566 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL5879046 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL5878981 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL5878962 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84
SCHEMBL16213094 1.00 GSTK1 (0.61) GSTK1FFAR4FFAR1ALDH1A1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153869-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2005-07-14 US claimed
US-20040097392-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2004-05-20 US claimed
US-20040092418-A1 Fatty acids, soaps surfactant systems, and consumer products based thereon CONNOR DANIEL STEDMAN (US) 2004-05-13 US claimed
US-20040092419-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2004-05-13 US claimed
US-20040087461-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2004-05-06 US claimed
CN-1283219-A Fatty acids, soaps, surfactant systems and consumer products based thereon PROCTER & GAMBLE (US) 2001-02-07 CN claimed
US-20170020893-A1 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERY LIPOCINE INC. (US) 2017-01-26 US disclosed
US-6992057-B2 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY (US) 2006-01-31 US disclosed
US-6949502-B2 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY (US) 2005-09-27 US disclosed
US-20050153869-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2005-07-14 US disclosed
US-6916777-B2 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY (US) 2005-07-12 US disclosed
US-6890894-B2 Fatty acids, soaps surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY (US) 2005-05-10 US disclosed
US-20040097392-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2004-05-20 US disclosed
US-20030236180-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2003-12-25 US disclosed
US-6602845-B2 Fatty acids, soaps, surfactant systems, and consumer products based thereon THE PROCTER & GAMBLE COMPANY 2003-08-05 US disclosed
US-20030100469-A1 Fatty acids, soaps, surfactant systems, and consumer products based thereon CONNOR DANIEL STEDMAN (US) 2003-05-29 US disclosed
US-6395701-B1 MIXTURE PROCTER & GAMBLE COMPANY, THE 2002-05-28 US disclosed
CN-1283219-A Fatty acids, soaps, surfactant systems and consumer products based thereon PROCTER & GAMBLE (US) 2001-02-07 CN disclosed
EP-1025190-A2 FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON THE PROCTER & GAMBLE COMPANY (US) 2000-08-09 EP disclosed
WO-1999020722-A2 FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON THE PROCTER & GAMBLE COMPANY (US) 1999-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170020893-A1 LIPOBALANCED LONG CHAIN TESTOSTERONE PRODRUGS FOR ORAL DELIVERY SHBG, CYP17A1, CYP19A1 GSTK1 434/4885FFAR4 276/4885FFAR1 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.